Summary
18.61 -0.68(-3.53%)07/01/2024
Safety Income and Growth Inc (SAFE)
Safety Income and Growth Inc (SAFE)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -3.53 | -3.72 | -3.32 | -7.41 | -21.48 | -23.57 | -35.88 | 8.88 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 18.61 | |
| Open | 19.24 | |
| High | 19.28 | |
| Low | 18.52 | |
| Volume | 185,605 | |
| Change | -0.68 | |
| Change % | -3.53 | |
| Avg Volume (20 Days) | 341,650 | |
| Volume/Avg Volume (20 Days) Ratio | 0.54 | |
| 52 Week Range | 15.00 - 26.33 | |
| Price vs 52 Week High | -29.32% | |
| Price vs 52 Week Low | 24.07% | |
| Range | -3.27 | |
| Gap Up/Down | -0.09 | |
Fundamentals | ||
| Market Capitalization (Mln) | 1,330 | |
| EBIDTA | 151,572,000 | |
| PE Ratio | 56.3600 | |
| PEG Ratio | 0.6500 | |
| WallStreet Target Price | 98.00 | |
| Book Value | 29.4550 | |
| Earnings Per Share | 1.2610 | |
| EPS Estimate Current Quarter | 0.3500 | |
| EPS Estimate Next Quarter | 0.3900 | |
| EPS Estimate Current Year | 1.3700 | |
| EPS Estimate Next Year | 1.7300 | |
| Diluted EPS (TTM) | 1.2610 | |
| Revenues | ||
| Profit Marging | 0.3734 | |
| Operating Marging (TTM) | 0.7763 | |
| Return on asset (TTM) | 0.0261 | |
| Return on equity (TTM) | 0.0462 | |
| Revenue TTM | 179,754,000 | |
| Revenue per share TTM | 3.3860 | |
| Quarterly Revenue Growth (YOY) | 0.2750 | |
| Quarterly Earnings Growth (YOY) | 0.3640 | |
| Gross Profit (TTM) | 156,251,000 | |
| Dividends | ||
| Dividend Share | 0.6640 | |
| Dividend Yield | 0.0092 | |
| Valuations | ||
| Trailing PE | 56.3600 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.4281 | |
| Revenue Enterprise Value | 34.5042 | |
| EBITDA Enterprise Value | 39.3966 | |
| Shares | ||
| Shares Outstanding | 56,559,900 | |
| Shares Float | 19,788,036 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 64.98 | |
| Institutions (%) | 35.95 | |
06/21 16:15 EST - prnewswire.com
Safehold Announces $750 Million Commercial Paper Note Program
NEW YORK , June 21, 2024 /PRNewswire/ -- Safehold Inc. (the "Company" or "Safehold") (NYSE: SAFE) today announced that its operating company, Safehold GL Holdings LLC (the "operating company"), has established an unsecured commercial paper note program in the United States. Under the terms of the program, the operating company may issue from time to time unsecured commercial paper notes up to a maximum aggregate amount outstanding at any one time of $750 million.
Safehold Announces $750 Million Commercial Paper Note Program
NEW YORK , June 21, 2024 /PRNewswire/ -- Safehold Inc. (the "Company" or "Safehold") (NYSE: SAFE) today announced that its operating company, Safehold GL Holdings LLC (the "operating company"), has established an unsecured commercial paper note program in the United States. Under the terms of the program, the operating company may issue from time to time unsecured commercial paper notes up to a maximum aggregate amount outstanding at any one time of $750 million.
06/14 08:00 EST - prnewswire.com
Safehold Declares Second Quarter 2024 Common Stock Dividend
NEW YORK , June 14, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE) announced today that the Company's Board of Directors has declared common stock dividends of $0.177 per share for the second quarter of 2024. The dividend represents an annualized rate of $0.708 per share and is payable on July 15, 2024 to holders of record on June 28, 2024.
Safehold Declares Second Quarter 2024 Common Stock Dividend
NEW YORK , June 14, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE) announced today that the Company's Board of Directors has declared common stock dividends of $0.177 per share for the second quarter of 2024. The dividend represents an annualized rate of $0.708 per share and is payable on July 15, 2024 to holders of record on June 28, 2024.
06/06 16:05 EST - prnewswire.com
Safehold Closes Ground Lease for Affordable Multifamily Development in Orange County, California
NEW YORK , June 6, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE), the creator and leader of the modern ground lease industry, has closed on a ground lease to facilitate the ground-up development of The Orion, a 166-unit senior affordable community in Orange, California. The project will be developed by USA Properties Fund, an experienced developer of multifamily projects throughout California.
Safehold Closes Ground Lease for Affordable Multifamily Development in Orange County, California
NEW YORK , June 6, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE), the creator and leader of the modern ground lease industry, has closed on a ground lease to facilitate the ground-up development of The Orion, a 166-unit senior affordable community in Orange, California. The project will be developed by USA Properties Fund, an experienced developer of multifamily projects throughout California.
05/28 10:52 EST - globenewswire.com
Paperclip to Showcase SAFE® Searchable Encryption at Gartner Security & Risk Management Summit 2024
Paperclip, Inc. (OTCMKTS:PCPJ) announced today its sponsorship of the Gartner Security & Risk Management Summit in National Harbor, Maryland June 3-5.
Paperclip to Showcase SAFE® Searchable Encryption at Gartner Security & Risk Management Summit 2024
Paperclip, Inc. (OTCMKTS:PCPJ) announced today its sponsorship of the Gartner Security & Risk Management Summit in National Harbor, Maryland June 3-5.
05/20 17:00 EST - https://www.businesswire.com
Taro Provides Results for Year Ended March 31, 2024
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2024. Quarter ended March 31, 2024 Highlights ─ compared to March 31, 2023 Net sales of $164.9 million increased $18.4 million, or 12.5%, principally due to new launches and gross-to-net (“GTN”) adjustments. Excluding the impact of GTN adjustments, sales growth was high single digits. Gross profit of $87.4 million (53.0% of net sales) compared to $75.7 million (51.6% of net sales). Research and development (R&D) expenses of $20.5 million increased $4.2 million. Selling, marketing, general and administrative expenses (SG&A) of $58.1 million included certain one-time charges of $1 million related to the Special Committee that was established by the Board to consider the proposal submitted by Sun Pharmaceutical Industries Ltd. on May 26, 2023. Excluding these charges, SG&A increased $7.0 million. Operating income was $ 8.8 million; excluding the impact from the GTN adjustments and the certain one-time charges for the quarter, the decline in the operating income was even higher. Interest and other financial income of $15.8 million increased $7.8 million. Tax expense of $11.2 million compared to a tax expense of $11.0 million. Net income attributable to Taro was $15.1 million compared to net income of $6.9 million, resulting in earnings per share of $0.40 compared to earnings per share of $0.18. Excluding the impact from the certain one-time charges, net income was $16.1 million, resulting in diluted earnings per share of $0.43. Year ended March 31, 2024 Highlights ─ compared to March 31, 2023 Net sales of $629.2 million increased $56.2 million or 9.8%, principally due to new launches and one-time GTN adjustments. Excluding these adjustments, the sales growth was mid-single-digits. Gross profit of $305.0 million (48.5% of net sales compared to 46.8%) increased $36.6 million. R&D expenses of $64.5 million increased $12.3 million. SG&A of $219.0 million included certain one-time charges of $14.2 million related to the aforementioned certain one-time charges and transitional expenses for the relocation of our Alchemee operations from California to New York. Excluding these charges, SG&A was $204.7 million, increased 3.2% above the prior year. Operating income was $21.5 million; excluding the impact from the GTN adjustments and the certain one-time charges during the current year, the resulting operating income was lower than the previous year. Interest and other financial income of $56.2 million increased $35.3 million from $20.9 million. Tax expense of $28.8 million compared to tax expense of $12.8 million, an increase of $16.0 million. Net income attributable to Taro was $53.9 million compared to $25.4 million, resulting in earnings per share of $1.43 compared to earnings per share of $0.68. Excluding the impact from the certain one-time charges, net income was $66.3 million, resulting in diluted earnings per share of $1.77. Cash Flow and Balance Sheet Highlights Cash flow provided by operations for the year ended March 31, 2024 was $124.6 million compared to $31.8 million for the year ended March 31, 2023. Excluding the impact from certain one-time charges impacting both years, cash flow provided by operations was $137.0 million compared to $99.0 million for the year ended March 31, 2023. As of March 31, 2024, cash and cash equivalents, short-term bank deposits and marketable securities (both short- and long-term) was $1.3 billion, or $82.2 million more than March 31, 2023. The Company cautions that the foregoing 2024 financial information is unaudited and is subject to change. ************************ About Taro Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com. SAFE HARBOR STATEMENT The unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements, and, in the opinion of management, reflect all adjustments necessary to present fairly the financial condition and results of operations of the Company. The unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 20-F, as filed with the SEC. Certain statements in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements that do not describe historical facts or that refer or relate to events or circumstances the Company “estimates,” “believes,” or “expects” to happen or similar language, and statements with respect to the Company’s financial performance, availability of financial information, and estimates of financial results and information for fiscal year 2025. Although the Company believes the expectations reflected in such forward-looking statements to be based on reasonable assumptions, it can give no assurances that its expectations will be attained. Factors that could cause actual results to differ include general domestic and international economic conditions, industry and market conditions, changes in the Company's financial position, litigation brought by any party in any court in Israel, the United States, or any country in which Taro operates, regulatory and legislative actions in the countries in which Taro operates, and other risks detailed from time to time in the Company’s SEC reports, including its Annual Reports on Form 20-F. Forward-looking statements are applicable only as of the date on which they are made. The Company undertakes no obligations to update, change or revise any forward-looking statement, whether as a result of new information, additional or subsequent developments or otherwise. **Financial Tables Follow** 2024 2023 2024 2023 $ 164,941 $ 146,587 $ 629,182 $ 572,952 77,552 70,879 324,203 304,629 — — 23 — 87,389 75,708 304,956 268,323 20,478 16,306 64,536 52,243 58,127 50,128 218,935 198,366 8,784 9,274 21,485 17,714 (15,834 ) (8,036 ) (56,192 ) (20,850 ) 588 469 (9 ) 2,813 2,198 1,059 4,981 2,462 26,228 17,900 82,668 38,213 11,150 10,987 28,801 12,768 $ 15,078 $ 6,913 $ 53,867 $ 25,445 $ 0.40 $ 0.18 $ 1.43 $ 0.68 37,584,891 37,584,891 37,584,891 37,584,891 * For the quarter ended March 31, 2024, excluding the impact from the certain one-time charges of $1.0 million (see page one of release for a description), operating income was $9.8 million. compared to operating income of $8.8 million. Excluding the impact of the certain one-time charges, net income was $16.1 million, resulting in earnings per share of $0.43. * For the full year ended March 31, 2024, excluding the impact from the certain one-time charges of $14.2 million (see page one of release for a description), operating income was $35.7 million compared to $21.5 million. Excluding the impact of the certain one-time charges, net income was $66.3 million, resulting in earnings per share of $1.77. 2024 2023 $ 362,909 $ 154,495 58,947 119,980 457,495 575,814 177,463 202,260 41,772 57,210 204,817 226,669 1,303,403 1,336,428 457,991 404,896 217,592 190,139 83,397 103,672 17,231 17,231 82,455 83,147 $ 2,162,069 $ 2,135,513 $ 44,664 $ 68,484 316,443 317,064 361,107 385,548 7,956 19,106 369,063 404,654 1,793,006 1,730,859 $ 2,162,069 $ 2,135,513 2024 2023 $ 53,867 $ 25,445 31,094 32,127 23 — — 136 — (24 ) — (15,292 ) 242 — (86 ) 2,291 19,148 16,802 24,481 37,482 21,728 (16,922 ) 15,730 2,240 (33,839 ) (60,707 ) (7,833 ) 8,172 124,555 31,750 (53,971 ) (17,553 ) (247 ) (294 ) 58,338 (72,394 ) 81,723 (33,315 ) (1,500 ) (2,000 ) 84,343 (125,556 ) (483 ) (2,833 ) 208,415 (96,639 ) 154,495 251,134 $ 362,910 $ 154,495 $ 18,309 $ 4,175 $ 12,931 $ 14,156 $ 2,041 $ 1,242 $ 4,602 $ 3,038
Taro Provides Results for Year Ended March 31, 2024
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2024. Quarter ended March 31, 2024 Highlights ─ compared to March 31, 2023 Net sales of $164.9 million increased $18.4 million, or 12.5%, principally due to new launches and gross-to-net (“GTN”) adjustments. Excluding the impact of GTN adjustments, sales growth was high single digits. Gross profit of $87.4 million (53.0% of net sales) compared to $75.7 million (51.6% of net sales). Research and development (R&D) expenses of $20.5 million increased $4.2 million. Selling, marketing, general and administrative expenses (SG&A) of $58.1 million included certain one-time charges of $1 million related to the Special Committee that was established by the Board to consider the proposal submitted by Sun Pharmaceutical Industries Ltd. on May 26, 2023. Excluding these charges, SG&A increased $7.0 million. Operating income was $ 8.8 million; excluding the impact from the GTN adjustments and the certain one-time charges for the quarter, the decline in the operating income was even higher. Interest and other financial income of $15.8 million increased $7.8 million. Tax expense of $11.2 million compared to a tax expense of $11.0 million. Net income attributable to Taro was $15.1 million compared to net income of $6.9 million, resulting in earnings per share of $0.40 compared to earnings per share of $0.18. Excluding the impact from the certain one-time charges, net income was $16.1 million, resulting in diluted earnings per share of $0.43. Year ended March 31, 2024 Highlights ─ compared to March 31, 2023 Net sales of $629.2 million increased $56.2 million or 9.8%, principally due to new launches and one-time GTN adjustments. Excluding these adjustments, the sales growth was mid-single-digits. Gross profit of $305.0 million (48.5% of net sales compared to 46.8%) increased $36.6 million. R&D expenses of $64.5 million increased $12.3 million. SG&A of $219.0 million included certain one-time charges of $14.2 million related to the aforementioned certain one-time charges and transitional expenses for the relocation of our Alchemee operations from California to New York. Excluding these charges, SG&A was $204.7 million, increased 3.2% above the prior year. Operating income was $21.5 million; excluding the impact from the GTN adjustments and the certain one-time charges during the current year, the resulting operating income was lower than the previous year. Interest and other financial income of $56.2 million increased $35.3 million from $20.9 million. Tax expense of $28.8 million compared to tax expense of $12.8 million, an increase of $16.0 million. Net income attributable to Taro was $53.9 million compared to $25.4 million, resulting in earnings per share of $1.43 compared to earnings per share of $0.68. Excluding the impact from the certain one-time charges, net income was $66.3 million, resulting in diluted earnings per share of $1.77. Cash Flow and Balance Sheet Highlights Cash flow provided by operations for the year ended March 31, 2024 was $124.6 million compared to $31.8 million for the year ended March 31, 2023. Excluding the impact from certain one-time charges impacting both years, cash flow provided by operations was $137.0 million compared to $99.0 million for the year ended March 31, 2023. As of March 31, 2024, cash and cash equivalents, short-term bank deposits and marketable securities (both short- and long-term) was $1.3 billion, or $82.2 million more than March 31, 2023. The Company cautions that the foregoing 2024 financial information is unaudited and is subject to change. ************************ About Taro Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com. SAFE HARBOR STATEMENT The unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements, and, in the opinion of management, reflect all adjustments necessary to present fairly the financial condition and results of operations of the Company. The unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 20-F, as filed with the SEC. Certain statements in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements that do not describe historical facts or that refer or relate to events or circumstances the Company “estimates,” “believes,” or “expects” to happen or similar language, and statements with respect to the Company’s financial performance, availability of financial information, and estimates of financial results and information for fiscal year 2025. Although the Company believes the expectations reflected in such forward-looking statements to be based on reasonable assumptions, it can give no assurances that its expectations will be attained. Factors that could cause actual results to differ include general domestic and international economic conditions, industry and market conditions, changes in the Company's financial position, litigation brought by any party in any court in Israel, the United States, or any country in which Taro operates, regulatory and legislative actions in the countries in which Taro operates, and other risks detailed from time to time in the Company’s SEC reports, including its Annual Reports on Form 20-F. Forward-looking statements are applicable only as of the date on which they are made. The Company undertakes no obligations to update, change or revise any forward-looking statement, whether as a result of new information, additional or subsequent developments or otherwise. **Financial Tables Follow** 2024 2023 2024 2023 $ 164,941 $ 146,587 $ 629,182 $ 572,952 77,552 70,879 324,203 304,629 — — 23 — 87,389 75,708 304,956 268,323 20,478 16,306 64,536 52,243 58,127 50,128 218,935 198,366 8,784 9,274 21,485 17,714 (15,834 ) (8,036 ) (56,192 ) (20,850 ) 588 469 (9 ) 2,813 2,198 1,059 4,981 2,462 26,228 17,900 82,668 38,213 11,150 10,987 28,801 12,768 $ 15,078 $ 6,913 $ 53,867 $ 25,445 $ 0.40 $ 0.18 $ 1.43 $ 0.68 37,584,891 37,584,891 37,584,891 37,584,891 * For the quarter ended March 31, 2024, excluding the impact from the certain one-time charges of $1.0 million (see page one of release for a description), operating income was $9.8 million. compared to operating income of $8.8 million. Excluding the impact of the certain one-time charges, net income was $16.1 million, resulting in earnings per share of $0.43. * For the full year ended March 31, 2024, excluding the impact from the certain one-time charges of $14.2 million (see page one of release for a description), operating income was $35.7 million compared to $21.5 million. Excluding the impact of the certain one-time charges, net income was $66.3 million, resulting in earnings per share of $1.77. 2024 2023 $ 362,909 $ 154,495 58,947 119,980 457,495 575,814 177,463 202,260 41,772 57,210 204,817 226,669 1,303,403 1,336,428 457,991 404,896 217,592 190,139 83,397 103,672 17,231 17,231 82,455 83,147 $ 2,162,069 $ 2,135,513 $ 44,664 $ 68,484 316,443 317,064 361,107 385,548 7,956 19,106 369,063 404,654 1,793,006 1,730,859 $ 2,162,069 $ 2,135,513 2024 2023 $ 53,867 $ 25,445 31,094 32,127 23 — — 136 — (24 ) — (15,292 ) 242 — (86 ) 2,291 19,148 16,802 24,481 37,482 21,728 (16,922 ) 15,730 2,240 (33,839 ) (60,707 ) (7,833 ) 8,172 124,555 31,750 (53,971 ) (17,553 ) (247 ) (294 ) 58,338 (72,394 ) 81,723 (33,315 ) (1,500 ) (2,000 ) 84,343 (125,556 ) (483 ) (2,833 ) 208,415 (96,639 ) 154,495 251,134 $ 362,910 $ 154,495 $ 18,309 $ 4,175 $ 12,931 $ 14,156 $ 2,041 $ 1,242 $ 4,602 $ 3,038
05/10 07:18 EST - prnewswire.com
Star Holdings Reports First Quarter 2024 Results
NEW YORK , May 10, 2024 /PRNewswire/ -- Star Holdings (NASDAQ: STHO) announced today that it has filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 with the Securities and Exchange Commission. Net income (loss) attributable to common shareholders for the first quarter was ($49.0 million) and earnings (loss) per share was ($3.68).
Star Holdings Reports First Quarter 2024 Results
NEW YORK , May 10, 2024 /PRNewswire/ -- Star Holdings (NASDAQ: STHO) announced today that it has filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 with the Securities and Exchange Commission. Net income (loss) attributable to common shareholders for the first quarter was ($49.0 million) and earnings (loss) per share was ($3.68).
05/07 12:55 EST - seekingalpha.com
Safehold Inc. (SAFE) Q1 2024 Earnings Call Transcript
Safehold Inc. (NYSE:SAFE ) Q1 2024 Earnings Conference Call May 7, 2024 9:00 AM ET Company Participants Pearse Hoffmann – Senior Vice President-Capital Markets and Investor Relations Jay Sugarman – Chairman and Chief Executive Officer Brett Asnas – Chief Financial Officer Tim Doherty – Chief Investment Officer Conference Call Participants Nate Crossett – BNP Anthony Paolone – JPMorgan Haendel St. Juste – Mizuho Mitch Germain – Citizens Rich Anderson – Wedbush Kenneth Lee – RBC Harsh Hemnani – Green Street Stephen Laws – Raymond James Kelly Kunath – Morgan Stanley Matthew Howlett – B. Riley Operator Good morning and welcome to Safehold's First Quarter 2024 Earnings Conference Call.
Safehold Inc. (SAFE) Q1 2024 Earnings Call Transcript
Safehold Inc. (NYSE:SAFE ) Q1 2024 Earnings Conference Call May 7, 2024 9:00 AM ET Company Participants Pearse Hoffmann – Senior Vice President-Capital Markets and Investor Relations Jay Sugarman – Chairman and Chief Executive Officer Brett Asnas – Chief Financial Officer Tim Doherty – Chief Investment Officer Conference Call Participants Nate Crossett – BNP Anthony Paolone – JPMorgan Haendel St. Juste – Mizuho Mitch Germain – Citizens Rich Anderson – Wedbush Kenneth Lee – RBC Harsh Hemnani – Green Street Stephen Laws – Raymond James Kelly Kunath – Morgan Stanley Matthew Howlett – B. Riley Operator Good morning and welcome to Safehold's First Quarter 2024 Earnings Conference Call.
05/06 19:31 EST - zacks.com
Safehold (SAFE) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Safehold (SAFE) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Safehold (SAFE) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Safehold (SAFE) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
05/06 16:05 EST - prnewswire.com
Safehold Reports First Quarter 2024 Results
NEW YORK , May 6, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE) reported results for the first quarter 2024. SAFE published a presentation detailing these results which can be found on its website, www.safeholdinc.com in the "Investors" section.
Safehold Reports First Quarter 2024 Results
NEW YORK , May 6, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE) reported results for the first quarter 2024. SAFE published a presentation detailing these results which can be found on its website, www.safeholdinc.com in the "Investors" section.
04/26 17:05 EST - seekingalpha.com
Are The 6.6% Yielding A Rated Bonds A Safehold?
In our previous coverage we had suggested that Safehold bonds were a better bet than the common shares. That thesis has played out quite well over time, despite the pressures of rising interest rates. We look at the latest bonds from Safehold, which sport the highest yield in its stack.
Are The 6.6% Yielding A Rated Bonds A Safehold?
In our previous coverage we had suggested that Safehold bonds were a better bet than the common shares. That thesis has played out quite well over time, despite the pressures of rising interest rates. We look at the latest bonds from Safehold, which sport the highest yield in its stack.
04/22 08:00 EST - prnewswire.com
Safehold Sets First Quarter 2024 Earnings Release Date and Webcast
NEW YORK , April 22, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE) announced today that it will release its financial results for the first quarter 2024 after the market close on Monday, May 6, 2024. The Company will host an earnings conference call reviewing these results and its operations beginning at 9:00 a.m.
Safehold Sets First Quarter 2024 Earnings Release Date and Webcast
NEW YORK , April 22, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE) announced today that it will release its financial results for the first quarter 2024 after the market close on Monday, May 6, 2024. The Company will host an earnings conference call reviewing these results and its operations beginning at 9:00 a.m.
04/20 07:00 EST - seekingalpha.com
REIT Rally 2.0: Opportunity Awaits For Investment In High-Quality Gems
Inflation is rising, causing bond rates to increase and stock prices to fall. REITs, which are income-oriented and interest rate sensitive, are particularly affected. This creates a buying opportunity for high-quality REITs with long-term potential.
REIT Rally 2.0: Opportunity Awaits For Investment In High-Quality Gems
Inflation is rising, causing bond rates to increase and stock prices to fall. REITs, which are income-oriented and interest rate sensitive, are particularly affected. This creates a buying opportunity for high-quality REITs with long-term potential.
04/15 08:00 EST - prnewswire.com
Safehold Announces New $2.0 Billion Unsecured Revolving Credit Facility
NEW YORK , April 15, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE), the creator of the modern ground lease industry, announced today that it has closed on a new $2.0 billion unsecured revolving credit facility, which replaces Safehold's existing aggregate $1.85 billion unsecured revolving credit facilities. The new facility has a fully extended maturity date of May 1, 2029 which includes two six-month extension options.
Safehold Announces New $2.0 Billion Unsecured Revolving Credit Facility
NEW YORK , April 15, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE), the creator of the modern ground lease industry, announced today that it has closed on a new $2.0 billion unsecured revolving credit facility, which replaces Safehold's existing aggregate $1.85 billion unsecured revolving credit facilities. The new facility has a fully extended maturity date of May 1, 2029 which includes two six-month extension options.
04/13 07:30 EST - seekingalpha.com
My Biggest Losses And Lessons
All investors, including even Warren Buffett, have suffered big losses. We take risks to earn returns and sometimes, risk factors play out. At other times, we also made mistakes in our analysis.
My Biggest Losses And Lessons
All investors, including even Warren Buffett, have suffered big losses. We take risks to earn returns and sometimes, risk factors play out. At other times, we also made mistakes in our analysis.
04/10 10:56 EST - zacks.com
Does Safehold (SAFE) Have the Potential to Rally 30.4% as Wall Street Analysts Expect?
The mean of analysts' price targets for Safehold (SAFE) points to a 30.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does Safehold (SAFE) Have the Potential to Rally 30.4% as Wall Street Analysts Expect?
The mean of analysts' price targets for Safehold (SAFE) points to a 30.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
04/10 07:30 EST - seekingalpha.com
10 Top REITs To Buy In 2024
REITs are offering a rare opportunity in 2024. Valuations are historically low and offer significant upside potential. Here are 10 REITs that deserve a "Buy" rating.
10 Top REITs To Buy In 2024
REITs are offering a rare opportunity in 2024. Valuations are historically low and offer significant upside potential. Here are 10 REITs that deserve a "Buy" rating.
03/15 16:05 EST - prnewswire.com
Safehold Declares First Quarter 2024 Common Stock Dividend
NEW YORK , March 15, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE) announced today that the Company's Board of Directors has declared common stock dividends of $0.177 per share for the first quarter of 2024. The dividend represents an annualized rate of $0.708 per share and is payable on April 15, 2024 to holders of record on March 28, 2024.
Safehold Declares First Quarter 2024 Common Stock Dividend
NEW YORK , March 15, 2024 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE) announced today that the Company's Board of Directors has declared common stock dividends of $0.177 per share for the first quarter of 2024. The dividend represents an annualized rate of $0.708 per share and is payable on April 15, 2024 to holders of record on March 28, 2024.
02/29 18:15 EST - prnewswire.com
Safehold Announces Pricing of $300 Million of Senior Unsecured Notes Due 2034
NEW YORK , Feb. 29, 2024 /PRNewswire/ -- Safehold Inc. (the "Company" or "Safehold") (NYSE: SAFE) today announced that its operating company, Safehold GL Holdings LLC (the "operating company"), has priced a public offering of $300 million aggregate principal amount of 6.100% senior notes due 2034 (the "Notes"). The Notes will mature on April 1, 2034.
Safehold Announces Pricing of $300 Million of Senior Unsecured Notes Due 2034
NEW YORK , Feb. 29, 2024 /PRNewswire/ -- Safehold Inc. (the "Company" or "Safehold") (NYSE: SAFE) today announced that its operating company, Safehold GL Holdings LLC (the "operating company"), has priced a public offering of $300 million aggregate principal amount of 6.100% senior notes due 2034 (the "Notes"). The Notes will mature on April 1, 2034.
02/27 16:44 EST - prnewswire.com
Star Holdings Reports Fourth Quarter and Fiscal Year 2023 Results
NEW YORK , Feb. 27, 2024 /PRNewswire/ -- Star Holdings (NASDAQ: STHO) announced today that it has filed its Annual Report on Form 10-K for the year ended December 31, 2023 with the Securities and Exchange Commission. Net income (loss) attributable to common shareholders was $66.1 million for the fourth quarter, and ($196.4) million for the year.
Star Holdings Reports Fourth Quarter and Fiscal Year 2023 Results
NEW YORK , Feb. 27, 2024 /PRNewswire/ -- Star Holdings (NASDAQ: STHO) announced today that it has filed its Annual Report on Form 10-K for the year ended December 31, 2023 with the Securities and Exchange Commission. Net income (loss) attributable to common shareholders was $66.1 million for the fourth quarter, and ($196.4) million for the year.
02/14 01:21 EST - seekingalpha.com
After Q4 Results And Share Price Drop, Safehold Is Still A Buy
Safehold's stock performance has not met my expectations in 2024, with losses of over 11% to date. The market repricing its expectations on interest rate cuts has been the key driver behind this drop. Despite this, Q4 2023 results show that Safehold continues to deliver stable financial performance and has strengthened its risk profile.
After Q4 Results And Share Price Drop, Safehold Is Still A Buy
Safehold's stock performance has not met my expectations in 2024, with losses of over 11% to date. The market repricing its expectations on interest rate cuts has been the key driver behind this drop. Despite this, Q4 2023 results show that Safehold continues to deliver stable financial performance and has strengthened its risk profile.